120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
中医药联合经动脉化疗栓塞治疗肝细胞癌：文献计量学分析
Authors Liu X , Zhang K, Wang Z, Zheng Y, Lin L, Wang J, Pan X, Li Y
Received 22 January 2026
Accepted for publication 9 April 2026
Published 21 April 2026 Volume 2026:13 598236
DOI https://doi.org/10.2147/JHC.S598236
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr David Gerber
Xiaolin Liu,1,* Kehui Zhang,1,* Zongyao Wang,2 Yiyuan Zheng,1 Liubing Lin,1 Jian Wang,1 Xiangxue Pan,1 Yong Li1
1Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Sartorius Stedim (Shanghai) Trading Co., Ltd, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Xiangxue Pan; Yong Li, Email costaserena@icloud.com; liyong@shutcm.edu.cn
Background: Increasingly, studies have indicated that traditional Chinese medicine (TCM) plus transarterial chemoembolization (TACE) has better efficacy and lower side effects for hepatocellular carcinoma (HCC) patients. However, there is a notable absence of visual evidence within the field of TCM plus TACE in HCC. Therefore, this study aimed to utilize bibliometric technology to visualize the research knowledge structure and identify emerging hotspots of TCM combined with TACE in HCC.
Methods: The publications relating to TCM plus TACE on HCC published up to October 17, 2025 were obtained from the Web of Science Core Collection (WoSCC) database. Bibliometric analysis was conducted using VOSviewer, CiteSpace, and the R-bibliometrix.
Results: A total of 399 publications were included in the analysis. The number of related publications and citations has steadily increased. China has established itself as the leading contributor to the literature in this field, with significant contributions also emanating from Japan and the USA. Among institutional contributors, the Sun Yat Sen University has demonstrated particular prominence in publication output. World Journal of Gastroenterology is the leading journal in this field. Cluster analysis indicated that current research hotspots include the systematic review and meta-analysis of TCM plus TACE on HCC, clinical prognosis, and pharmacological mechanisms. Trend analysis revealed that AI-based systems for diagnosis and management represent an emerging research frontier in this field.
Conclusion: This work serves as a framework for understanding the evolution and frontiers of the field, thereby paving the way for further scientific and clinical advances in the application of TCM with TACE for HCC. Consequently, more HCC patients can benefit from the methods of TCM plus TACE.
Keywords: traditional Chinese medicine, transarterial chemoembolization, hepatocellular carcinoma, bibliometric analysis
1Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Sartorius Stedim (Shanghai) Trading Co., Ltd, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Xiangxue Pan; Yong Li, Email costaserena@icloud.com; liyong@shutcm.edu.cn
Background: Increasingly, studies have indicated that traditional Chinese medicine (TCM) plus transarterial chemoembolization (TACE) has better efficacy and lower side effects for hepatocellular carcinoma (HCC) patients. However, there is a notable absence of visual evidence within the field of TCM plus TACE in HCC. Therefore, this study aimed to utilize bibliometric technology to visualize the research knowledge structure and identify emerging hotspots of TCM combined with TACE in HCC.
Methods: The publications relating to TCM plus TACE on HCC published up to October 17, 2025 were obtained from the Web of Science Core Collection (WoSCC) database. Bibliometric analysis was conducted using VOSviewer, CiteSpace, and the R-bibliometrix.
Results: A total of 399 publications were included in the analysis. The number of related publications and citations has steadily increased. China has established itself as the leading contributor to the literature in this field, with significant contributions also emanating from Japan and the USA. Among institutional contributors, the Sun Yat Sen University has demonstrated particular prominence in publication output. World Journal of Gastroenterology is the leading journal in this field. Cluster analysis indicated that current research hotspots include the systematic review and meta-analysis of TCM plus TACE on HCC, clinical prognosis, and pharmacological mechanisms. Trend analysis revealed that AI-based systems for diagnosis and management represent an emerging research frontier in this field.
Conclusion: This work serves as a framework for understanding the evolution and frontiers of the field, thereby paving the way for further scientific and clinical advances in the application of TCM with TACE for HCC. Consequently, more HCC patients can benefit from the methods of TCM plus TACE.
Keywords: traditional Chinese medicine, transarterial chemoembolization, hepatocellular carcinoma, bibliometric analysis